Value Sense
ELV
Elevance Health Inc. (ELV)
Last Price$395.5(0.3%)
Market Cap$90.7B
Intrinsic value score
7/10
Good
Intrinsic value
$1,001.8
DCF value - $1,618.1 Relative value - $385.6
Undervalued
153.3%
LTM P/E
15.2x
Peer set median 17.8x
Discount rate
8.2%
ELV
is 153.3% undervalued
learn more -->
50+
undervalued stocks
Start beating the S&P 500

ELV Intrinsic value

Key Highlights:
Relative Value vs Current Share Price
As of Mar 03, 2025 ELV Relative Value is $388.8, which is overvalued by 1.7%, compared to current share price of $395.5.
DCF Value vs Current Share Price
As of Mar 03, 2025 ELV DCF Value is $1,623.6, which is undervalued by 310.5%, compared to current share price of $395.5.
Methodology
Price per share, $
ELV
Intrinsic value$1,001.8
Undervalued by153.3%
Current share price
395.5
Relative value
388.8
DCF value
1,623.6

Best stock ideas on the market right now

With Value Sense, you can find undervalued stocks list with intrinsic value. Discover more stock market investment ideas.

Undervalued stocks right now

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Low P/E stocks

Low P/E stocks

Explore the best low P/E stocks to buy in 2025, featuring top companies trading at low P/E ratios.

3M Return 7.5%
S&P Outperformance -5.5%
Next 3M Predicted Return 10.2%
Undervalued dividend stocks

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.

3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%

ELV Historical Intrinsic Value

Crunching data... Almost there!

ELV vs Peer Set: Intrinsic Value Comparison

General

Intrinsic Value

Financials

Company name

Undervaluation/Overvaluation

Revenue growth

EPS growth

Net income margin

Elevance Health Inc. logo
Elevance Health Inc.ELV
153.3%
3.2%
(0.0%)
3.4%
Median Peer Set
8.7%
(11.9%)
1.1%
Alignment Healthcare, Inc. logo
Alignment Healthcare, Inc.ALHC
(47.0%)
27.2%
(4.8%)
(8.1%)
Clover Health Investments, Corp. logo
Clover Health Investments, Corp.CLOV
(45.3%)
(41.5%)
(31.3%)
(10.5%)
Molina Healthcare, Inc. logo
Molina Healthcare, Inc.MOH
37.0%
19.3%
9.2%
2.9%
Oscar Health, Inc. logo
Oscar Health, Inc.OSCR
57.0%
56.5%
N/A
0.3%
UnitedHealth Group Incorporated logo
UnitedHealth Group IncorporatedUNH
124.2%
8.9%
(35.7%)
3.6%
Cigna Corporation logo
Cigna CorporationCI
202.7%
8.4%
(18.9%)
2.6%
Humana Inc. logo
Humana Inc.HUM
205.0%
10.7%
(50.1%)
1.0%
CVS Health Corporation logo
CVS Health CorporationCVS
220.8%
4.2%
(43.6%)
1.2%
Bright Health Group, Inc. logo
Bright Health Group, Inc.BHG
463.3%
(51.9%)
86.2%
(103.4%)
Centene Corporation logo
Centene CorporationCNC
2,301.3%
5.9%
27.4%
2.0%

Explore more intrinsic value tools hub for ELV

DCF value calculator
Reverse DCF
Peter Lynch charts
Relative Value
Earnings growth model
Peter Lynch Fair Value
Margin of safety
Ben Graham Fair Value
Earnings Power Value
Discount rate

FAQ

What is Elevance Health Inc. intrinsic value?

As of Mar 03, 2025, Elevance Health Inc. Intrinsic Value is $1,001.8. This suggests it may be undervalued by 153.3% compared to its current price of around $395.5.

What is Elevance Health Inc. DCF (discounted cash flow) valuation?

As of Mar 03, 2025, Elevance Health Inc.'s Discounted Cash Flow (DCF) valuation estimates its share price at $1,623.6. This suggests it may be overvalued by 310.5% to its current price of around $395.5, using a discount rate of 8.2% and terminal growth rate of 3.0%.

Is Elevance Health Inc. overvalued or undervalued?

Elevance Health Inc. is currently considered undervalued based on its Discounted Cash Flow (DCF) valuation and Relative Valuation, which estimates its share price to be $1,001.8, compared to a market price of around $395.5. This suggests a potential undervaluation of 153.3%.